nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—F2—FOXA2 and FOXA3 transcription factor networks—CPT1B—narcolepsy	0.0762	0.0762	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—HCRTR2—narcolepsy	0.031	0.031	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—HCRTR1—narcolepsy	0.031	0.031	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—HCRTR2—narcolepsy	0.0306	0.0306	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—HCRTR1—narcolepsy	0.0306	0.0306	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—P2RY11—narcolepsy	0.03	0.03	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0278	0.0278	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0278	0.0278	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0268	0.0268	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—HCRT—narcolepsy	0.0255	0.0255	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—HCRT—narcolepsy	0.0252	0.0252	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.0228	0.0228	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—PENK—narcolepsy	0.0224	0.0224	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.0206	0.0206	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.0206	0.0206	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0198	0.0198	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—TRH—narcolepsy	0.0193	0.0193	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—TRH—narcolepsy	0.0191	0.0191	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.0173	0.0173	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0169	0.0169	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—HCRTR1—narcolepsy	0.0156	0.0156	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—HCRTR2—narcolepsy	0.0156	0.0156	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—P2RY11—narcolepsy	0.0151	0.0151	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.015	0.015	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—TAC1—narcolepsy	0.014	0.014	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—NPS—narcolepsy	0.014	0.014	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—TAC1—narcolepsy	0.0139	0.0139	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—NPS—narcolepsy	0.0139	0.0139	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—HCRT—narcolepsy	0.0129	0.0129	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.0128	0.0128	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.0125	0.0125	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.0125	0.0125	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—PENK—narcolepsy	0.0115	0.0115	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0112	0.0112	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—narcolepsy	0.0104	0.0104	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—TNF—narcolepsy	0.0103	0.0103	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—TRH—narcolepsy	0.00974	0.00974	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00929	0.00929	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00929	0.00929	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—HCRTR2—narcolepsy	0.00884	0.00884	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—HCRTR1—narcolepsy	0.00884	0.00884	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—P2RY11—narcolepsy	0.00854	0.00854	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—HRH3—narcolepsy	0.00854	0.00854	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—HTR2A—narcolepsy	0.00844	0.00844	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TNF—narcolepsy	0.00835	0.00835	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HCRTR2—narcolepsy	0.00803	0.00803	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HCRTR1—narcolepsy	0.00803	0.00803	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—P2RY11—narcolepsy	0.00776	0.00776	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00755	0.00755	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—HCRT—narcolepsy	0.00726	0.00726	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—TAC1—narcolepsy	0.00708	0.00708	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—NPS—narcolepsy	0.00708	0.00708	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—TNF—narcolepsy	0.00663	0.00663	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HCRT—narcolepsy	0.0066	0.0066	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PENK—narcolepsy	0.00647	0.00647	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PENK—narcolepsy	0.00588	0.00588	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00559	0.00559	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—TRH—narcolepsy	0.0055	0.0055	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—TRH—narcolepsy	0.005	0.005	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—HRH3—narcolepsy	0.00483	0.00483	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HCRTR1—narcolepsy	0.00474	0.00474	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HCRTR2—narcolepsy	0.00474	0.00474	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—P2RY11—narcolepsy	0.00458	0.00458	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HRH3—narcolepsy	0.00438	0.00438	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—HTR2A—narcolepsy	0.00426	0.00426	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—TAC1—narcolepsy	0.004	0.004	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—NPS—narcolepsy	0.004	0.004	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HCRT—narcolepsy	0.0039	0.0039	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—TAC1—narcolepsy	0.00363	0.00363	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—NPS—narcolepsy	0.00363	0.00363	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PENK—narcolepsy	0.00347	0.00347	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CHKB—narcolepsy	0.00297	0.00297	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TRH—narcolepsy	0.00295	0.00295	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HRH3—narcolepsy	0.00259	0.00259	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—HTR2A—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HTR2A—narcolepsy	0.00218	0.00218	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NPS—narcolepsy	0.00215	0.00215	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TAC1—narcolepsy	0.00215	0.00215	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CPT1B—narcolepsy	0.00202	0.00202	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CHKB—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HTR2A—narcolepsy	0.00129	0.00129	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000938	0.000938	CbGpPWpGaD
